RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 116 filers reported holding RAPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,571,986 | -11.1% | 94,584 | +0.0% | 0.00% | – |
| Q2 2023 | $1,768,365 | +3.7% | 94,565 | +1.7% | 0.00% | – |
| Q1 2023 | $1,705,486 | +4.5% | 92,942 | +12.8% | 0.00% | – |
| Q4 2022 | $1,631,976 | -15.9% | 82,423 | +2.2% | 0.00% | – |
| Q3 2022 | $1,941,000 | +47.8% | 80,652 | +12.1% | 0.00% | – |
| Q2 2022 | $1,313,000 | -9.3% | 71,967 | +9.4% | 0.00% | – |
| Q1 2022 | $1,447,000 | -40.3% | 65,787 | -0.3% | 0.00% | – |
| Q4 2021 | $2,423,000 | -7.9% | 65,971 | -22.1% | 0.00% | -100.0% |
| Q3 2021 | $2,631,000 | +16.5% | 84,727 | +19.2% | 0.00% | – |
| Q2 2021 | $2,259,000 | +120.2% | 71,085 | +53.8% | 0.00% | – |
| Q1 2021 | $1,026,000 | +10.9% | 46,207 | -1.2% | 0.00% | – |
| Q4 2020 | $925,000 | -3.4% | 46,776 | +57.2% | 0.00% | – |
| Q3 2020 | $958,000 | +12.0% | 29,749 | +0.8% | 0.00% | – |
| Q2 2020 | $855,000 | – | 29,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |